In the phase III OLYMPIA 1 trial, Nemolizumab as a monotherapy has significantly improved itch and skin lesions in adult ...
Leggi articolo
The phase 3 CheckMate -67T noninferiority trial evaluating the subcutaneous formulation of Opdivo ( Nivolumab ) co-formulated with Halozyme’s recombinant ...
Leggi articolo
Updated efficacy and safety results from the Teclistamab cohort of the phase 1b TriMM-2 study were presented at the 2022 ...
Leggi articolo
Farxiga ( Dapagliflozin ) is a first-in-class, oral, once-daily SGLT2 inhibitor. The research for Farxiga is advancing from cardiorenal effects ...
Leggi articolo
The European Commission ( EC ) has extended approval for Rinvoq ( Upadacitinib ) 15 mg to treat adult patients ...
Leggi articolo
The Food and Drug Administration ( FDA ) has approved Margenza ( Margetuximab-cmkb; Margetuximab ) in combination with chemotherapy, for ...
Leggi articolo
The primary endpoint of overall survival ( OS ) was met in a phase 3 trial comparing the PD-1 inhibitor ...
Leggi articolo
ELEKTRA was an international, multi-center, randomized, double-blind, placebo-controlled study designed to evaluate treatment with Soticlestat in pediatric patients, aged 2 ...
Leggi articolo
Lorlatinib ( Lorviqua ) is a 3rd-generation ALK tyrosine kinase inhibitor ( TKI ) developed to penetrate the central nervous ...
Leggi articolo
Drugs that inhibit the sodium-glucose co-transporter 2 ( SGLT2 ) have been shown to reduce the risk of hospitalizations for ...
Leggi articolo
The Food and Drug Administration ( FDA ) has granted accelerated approval to Lorlatinib ( Lorbrena ) for patients with ...
Leggi articolo
The FDA ( US Food and Drug Administration ) has granted accelerated approval for Keytruda ( Pembrolizumab ), an immunotherapy ...
Leggi articolo
The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) adopted ...
Leggi articolo
Among women in Europe, ovarian cancer is the fifth most common cancer and the sixth leading cause of cancer death. ...
Leggi articolo
The European Commission ( EC ) has licensed Fotivda ( Tivozanib ) for the management of adult patients with advanced ...
Leggi articolo
The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) has ...
Leggi articolo
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of ...
Leggi articolo
The journal Neuropsychopharmacology has published the CONNECT trial results. In the publication, the authors conclude that Vortioxetine ( Brintellix ) ...
Leggi articolo
Secukinumab ( Cosentyx ) has met the primary endpoints in two new clinical studies, showing superior efficacy compared to placebo ...
Leggi articolo
Solithromycin is a next-generation oral and intravenous fluoroketolide in development for the treatment of moderate to moderately-severe community acquired bacterial ...
Leggi articolo
Eravacycline is a broad-spectrum intravenous and oral antibiotic for the treatment of multidrug-resistant ( MDR ) infections, including those caused ...
Leggi articolo
Results from a new global survey of lung cancer oncologists have shown that despite 81% of newly diagnosed advanced non-small ...
Leggi articolo
The DYNAGITO study will assess the potential benefit of Tiotropium plus Olodaterol Respimat FDC ( fixed-dose combination ) compared to ...
Leggi articolo
Recent evidence has shown that use of anthracycline and taxane adjuvant chemotherapy and dose-dense regimens, consisting of more frequent administration ...
Leggi articolo
The dermatologic adverse events of various molecularly targeted therapies are well-described in adult cancer patients. Little has been reported on ...
Leggi articolo
In patients with advanced thyroid cancer, Sunitinib [ Sutent ], a drug approved for treatment of several other cancers, showed ...
Leggi articolo
Positive results from a Phase IIb study evaluating the efficacy, safety and tolerability of two doses of subcutaneous TEV-48125, an ...
Leggi articolo
Recently developed CGRP ( calcitonin gene-related peptide ) receptor antagonists have shown promising results in clinical trials for acute treatment ...
Leggi articolo
The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) has ...
Leggi articolo
Pirarubicin ( THP ) is a newer generation anthracycline anticancer drug with antineoplastic efficacy against numerous tumors.
Few studies have ...
Leggi articolo
L-Dopa-induced dyskinesias ( LID ) are the most common adverse effects of long-term dopaminergic therapy in Parkinson's disease ( PD ...
Leggi articolo
Researchers at University of Pisa ( Italy ) have evaluated the effectiveness of intravenous Iloprost ( IVI ) in outpatients ...
Leggi articolo
The European Commission has granted marketing authorization for Zydelig ( Idelalisib ), 150 mg tablets, a first-in-class oral treatment for ...
Leggi articolo
Pacritinib has been granted Fast Track designation by the FDA ( Food and Drug Administration ) for the treatment of ...
Leggi articolo
The first phase III data for the once-daily fixed-dose combination of Tiotropium and Olodaterol were presented at American Thoracic Society ...
Leggi articolo
Eisai has announced that the phase 3 SELECT trial ( Study 303 ) of investigational agent Lenvatinib met its primary ...
Leggi articolo
Boehringer Ingelheim has announced results showing that its investigational fully humanized antibody fragment ( Fab ) rapidly reversed the anticoagulation ...
Leggi articolo
The FDA ( Food and Drug Administration ) is warning that Methylphenidate products, one type of stimulant drug used to ...
Leggi articolo
The Food and Drug Administration ( FDA ) has approved Cimzia ( Certolizumab pegol ) for the treatment of adults ...
Leggi articolo
The Food and Drug Administration ( FDA ) has approved Opsumit ( Macitentan ), a new drug to treat adults ...
Leggi articolo
Lundbeck and Otsuka Pharmaceutical have announced a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human ...
Leggi articolo
Bayer HealthCare has announced that the European Committee for Medicinal Products for Human Use ( CHMP ) recommended Radium Ra ...
Leggi articolo
Incyte has announced results from two ongoing clinical trials of Jakafi ( Ruxolitinib ), an oral JAK1 and JAK2 inhibitor ...
Leggi articolo
Roche has announced that a new injectable ( subcutaneous ) formulation of Herceptin ( Trastuzumab ) has been approved by ...
Leggi articolo
Amgen has announced that the FDA ( Food and Drug Administration ) has approved a new indication for Xgeva ( ...
Leggi articolo
Bristol-Myers Squibb ( BMS ) has announced the results of year two data from AMPLE ( Abatacept Versus Adalimumab Comparison ...
Leggi articolo
The FDA ( Food and Drug Administration ) has warned the public that the anti-seizure medication Potiga ( Ezogabine; Retigabine ...
Leggi articolo
The oral anticoagulant Xarelto ( Rivaroxaban ) has been approved by the European Commission for the prevention of atherothrombotic events ...
Leggi articolo
The Food and Drug Administration ( FDA ) has approved Kcentra ( Prothrombin Complex Concentrate, Human ) for the urgent ...
Leggi articolo
Bayer HealthCare has announced that the FDA ( Food and Drug Administration ) has approved Xofigo ( Radium 223 dichloride ...
Leggi articolo
Baxter International has announced that its Phase III clinical study of Immunoglobulin ( IG ) did not meet its co-primary ...
Leggi articolo
Otsuka has informed of significant liver injury associated with the use of Tolvaptan ( Samsca ). In a large double-blind, ...
Leggi articolo
Interim analysis of a large, randomized clinical trial has shown that patients with advanced, recurrent, or persistent cervical cancer that ...
Leggi articolo
Teriflunomide ( Aubagio ) is an immunomodulatory drug inhibiting pyrimidine de novo synthesis by blocking the enzyme dihydroorotate dehydrogenase. Teriflunomide ...
Leggi articolo
In Canada, Docetaxel ( Taxotere ) is an injectable chemotherapy drug that was first marketed on December 31, 1995. It ...
Leggi articolo
Roflumilast ( Daxas ) is a phosphodiesterase-type-4 ( PDE4 ) inhibitor used for maintenance treatment of severe chronic obstructive pulmonary ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved Invokana ( Canagliflozin ) tablets, used with diet and exercise, ...
Leggi articolo
The FDA ( Food and Drug Administration ) Pulmonary-Allergy Drugs Advisory Committee ( PADAC ) has recommended that clinical data ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved Tecfidera ( Dimethyl fumarate ) capsules to treat adults with ...
Leggi articolo
The European Committee for Medicinal Products for Human Use ( CHMP ) has recommended approval of oral anticoagulant Xarelto ( ...
Leggi articolo
Amgen has announced top-line results from the phase 3 trial in melanoma, which has evaluated the efficacy and safety of ...
Leggi articolo
The FDA ( Food and Drug Administration ) is evaluating unpublished new findings by a group of academic researchers that ...
Leggi articolo
The FDA ( Food and Drug Administration ) is warning the public that Azithromycin ( Zithromax or Zmax ) can ...
Leggi articolo
Celgene has announced that statistical significance for the primary endpoint of PASI 75 at week 16 was achieved for patients ...
Leggi articolo
The U.S. Food and Drug Administration ) has approved Kadcyla ( Ado-Trastuzumab Emtansine ), a new therapy for patients with ...
Leggi articolo
The FDA ( Food and Drug Administration ) has expanded the approved use of Stivarga ( Regorafenib ) to treat ...
Leggi articolo
Gilead Sciences has announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the ...
Leggi articolo
Roche has announced that the FDA ( Food and Drug Administration ) has approved a new use of Avastin ( ...
Leggi articolo
Merck, known as MSD outside of the United States and Canada, has announced the company is taking steps to suspend ...
Leggi articolo
The FDA ( Food and Drug Administration ) approved Juxtapid ( Lomitapide ) to reduce low-density lipoprotein ( LDL ...
Leggi articolo
Galderma Laboratories has announced the availability of a new pump dispenser design for MetroGel ( Metronidazole ) Gel, 1%, the ...
Leggi articolo
Amgen has announced the FDA ( Food and Drug Administration ) has approved a new indication for Prolia ( Denosumab ...
Leggi articolo
Excess weight and obesity in the general population are increasing problems throughout the Western world, and this rise has also ...
Leggi articolo
Genzyme, a Sanofi company, has announced that the FDA ( Food and Drug Administration ) has approved Aubagio ( Teriflunomide ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved the anti-clotting drug Eliquis ( Apixaban ), an oral tablet ...
Leggi articolo
Forxiga ( Dapagliflozin ) is the first SGLT2 ( sodium/glucose cotransporter 2 ) class drug. Forxiga has obtained marketing approval ...
Leggi articolo
European Commission has approved Humira ( Adalimumab ) for the treatment of pediatric patients aged six to 17 years with ...
Leggi articolo
GlaxoSmithKline ( GSK ) has announced that the FDA ( Food and Drug Administration ) has approved Promacta ( Eltrombopag; ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved Bosulif ( Bosutinib ) to treat chronic myelogenous leukemia ( ...
Leggi articolo
The Food and Drug Administration ( FDA ) has received reports of serious skin reactions, some fatal, in patients taking ...
Leggi articolo
Roche has announced that the European Commission ( EC ) has approved Avastin ( Bevacizumab ) in combination with standard ...
Leggi articolo
Cases of severe symptomatic hypocalcaemia have occurred in patients receiving Denosumab 120 mg ( Xgeva ) or 60 mg ( ...
Leggi articolo
Carbamazepine ( Tegretol ) is an antiepileptic drug that is indicated for the treatment of generalised tonic clonic seizures. Carbamazepine ...
Leggi articolo
The EMA ( European Medicines Agency ) has finalised a review of recently published information on the cardiovascular safety of ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved Pertuzumab injection ( Perjeta ) for use in combination with ...
Leggi articolo
Promacta may cause hepatotoxicity. Promacta, in combination with Interferon and Ribavirin in patients with chronic hepatitis C, may increase the ...
Leggi articolo
Bayer HealthCare has announced that Eylea ( Aflibercept solution for injection ), also known as VEGF Trap-Eye, has been approved ...
Leggi articolo
European Commission ( EC ) has approved oral anticoagulant Xarelto ( Rivaroxaban ) for the treatment of pulmonary embolism ( ...
Leggi articolo
Janssen has announced that the investigational agent Canagliflozin substantially lowers blood glucose levels compared to placebo when used as add-on ...
Leggi articolo
Janssen has announced that use of the investigational agent Canagliflozin substantially has lowered blood glucose levels when used as add-on ...
Leggi articolo
Bristol-Myers Squibb and AstraZeneca have announced that the European Commission has approved Forxiga ( Dapagliflozin ) tablets for the treatment ...
Leggi articolo
The FDA ( Food and Drug Administration ) has approved Xeljanz ( Tofacitinib ) to treat adults with moderately to ...
Leggi articolo
The FDA ( Food and Drug Administration ) has expanded the approved use of Xarelto ( Rivaroxaban ) to include ...
Leggi articolo
Fixed-dose unmonitored treatment with Dabigatran etexilate ( Pradaxa ) is effective and has a favorable safety profile in prevention of ...
Leggi articolo
The EORTC 62012 trial attempted to resolve controversy regarding whether Ifosfamide ( Holoxan ) had been previously tested at too ...
Leggi articolo
La Food and Drug Administration ( FDA ) has approved a new indication for Prolia ( Denosumab ) as a ...
Leggi articolo
Bayer HealthCare has announced that the Food and Drug Administration ( FDA ) approved Stivarga ( Regorafenib ) tablets for ...
Leggi articolo
The FDA ( Food and Drug Administration ) has informed the public about a possible increased risk of heart failure ...
Leggi articolo
Celgene has announced that statistical significance for the primary endpoint of ACR20 at week 16 was achieved for patients receiving ...
Leggi articolo
Bayer HealthCare has announced that Kogenate ( Octocog alfa ) is effective and well tolerated at reducing bleeding frequency in ...
Leggi articolo